Optimization in Drug Discovery
(Sprache: Englisch)
A panel of researchers and experts from leading universities and major pharmaceutical companies from all over the world systematically describe cutting-edge experimental protocols for the early in vitro evaluation of new chemical entities (NCE). These...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
160.49 €
Produktdetails
Produktinformationen zu „Optimization in Drug Discovery “
A panel of researchers and experts from leading universities and major pharmaceutical companies from all over the world systematically describe cutting-edge experimental protocols for the early in vitro evaluation of new chemical entities (NCE). These readily reproducible assays measure such critical parameters as physicochemical properties, adsorption, plasma binding, metabolism, drug interactions, and toxicity. By uncovering early in the discovery stage the defects that can eliminate candidate drugs from preclinical and clinical development, these techniques can save millions of dollars in time and effort.
Klappentext zu „Optimization in Drug Discovery “
Recent analyses of drug attrition rates reveal that a significant number of drug candidates fail in the later stage of clinical development owing to absorption, distribution, metabolism, elimination (ADME), and toxicity issues. Lead optimization in drug discovery, a process attempting to uncover and correct these defects of drug candidates, is highly beneficial in lowering the cost and time to develop therapeutic drugs by reducing drug candidate failures in development. At present, parallel synthesis combining with high-throughput screening has made it easier to generate highly potent compounds (i. e. , hits). However, to be a potential drug, a hit must have drug-like characteristics in addition to potency, which include optimal physicochemical properties, reasonable ph- macokinetic parameters, and good safety profiles. Therefore, research tools must be available in drug discovery to rapidly screen for compounds with favorable drug-like properties, and thus adequate resources can be directed to projects with high potential. Optimization in Drug Discovery: In Vitro Methods is a compilation of detailed experimental protocols necessary for setting up a variety of assays important in compound evaluation. A total of 25 chapters, contributed by many experts in their research areas, cover a wide spectrum of subjects including physicochemical properties, abso- tion, plasma binding, metabolism, drug interactions, and toxicity. A good pharmacokinetic profile has long been recognized as an imp- tant drug-like characteristic. Pharmacokinetic parameters are affected by many properties of drug molecules such as physicochemical nature, abso- tion, metabolic stability, and so on.
Inhaltsverzeichnis zu „Optimization in Drug Discovery “
pKa, Solubility, and Lipophilicity.- Use of Caco-2 Cell Monolayers to Study Drug Absorption and Metabolism.- Absorption Screening Using the PAMPA Approach.- In Situ Single-Pass Perfused Rat Intestinal Model for Absorption and Metabolism.- In Vitro Permeation Study With Bovine Brain Microvessel Endothelial Cells.- An Enzymatic Microplate Assay for Testing P-Glycoprotein Substrates and Inhibitors.- Evaluation of Drug-Transporter Interactions Using In Vitro Cell Models.- Plasma Protein-Binding Methods in Drug Discovery.- Isothermal Titration Calorimetry Characterization of Drug-Binding Energetics to Blood Proteins.- Metabolic Stability Assessed by Liver Microsomes and Hepatocytes.- In Vitro Drug Metabolite Profiling Using Hepatic S9 and Human Liver Microsomes.- In Vitro Identification of UDP-Glucuronosyltransferases (UGTs) Involved in Drug Metabolism.- In Vitro CYP Induction in Human Hepatocytes.- High-Throughput Screening of Human Cytochrome P450 Inhibitors Using Fluorometric Substrates.- Evaluation of Cytochrome P450 Inhibition in Human Liver Microsomes.- Identification of CYP Mechanism-Based Inhibitors.- Detection of DNA Adducts by 32P-Postlabeling Analysis.- Covalent DNA Adduct Formation Mediated by Cytochrome P450.- Application of In Vitro Comet Assay for Genotoxicity Testing.- Assessing DNA Damage Using a Reporter Gene System.- Improvement of the Ames Test Using Human Liver S9 Preparation.- Screening for Chemical Mutagens Using the Mouse Lymphoma Assay.- A High-Throughput Binding Assay for HERG.- In Vitro Drug Metabolism.- In Vitro Screening Assay of the Reactivity of Acyl Glucuronides.
Bibliographische Angaben
- 2010, Softcover reprint of hardcover 1st ed. 2004, XVI, 420 Seiten, Maße: 15,2 x 22,9 cm, Kartoniert (TB), Englisch
- Herausgegeben: Zhengyin Yan, Gary W. Caldwell
- Verlag: Springer, Berlin
- ISBN-10: 1617374997
- ISBN-13: 9781617374999
Sprache:
Englisch
Rezension zu „Optimization in Drug Discovery “
Aus den Rezensionen:"... Wo liegen die Schwierigkeiten, woran sind frühere Entwicklungen gescheitert? Dies sind Fragen, die ... mit großem Sachverstand beantwortet werden. ... Je Später ein Arzneimittelkandidat in der Entwicklung scheitert, desto größer ist der finanzielle Verlust für den pharmazeutischen Unternehmer. ... dieser Verlust kann ... über den Verkauf von zugelassenen Arzneimitteln wieder wettgemacht werden. Um diese Risiken möglicher niedrig zu halten, ist das ... Buch eine gute Wissensquelle, um die Entwicklung der Arzneimittel zu optimieren. ... Der lange Weg zum Lebensretter - ein Blick hinter die Kulissen der Medikamentenentwicklung."(Stefan Hockertz, Methods in Pharmacology and Toxicology, in: Arzneimittel - Forschung, 2005, Vol. 55, Issue 7, S. 428)
Pressezitat
"This book covers most of the currently used techniques in lead optimization with respect to ADME and safety profiles. . .would be very useful addition to the library of any drug scientist interested in an introduction to these important methods. Each chapter treats its topic in a concise manner and provides ample references to lead the reader to more detailed information."-Doody's Health Sciences Book Review Journal"...very useful technically...invaluable to those changing roles or joining a pharmaceutical company, it is also very helpful for scientists in the biotech industry who are new to drug discovery." - Immunology News
"The book provides a wealth of relevant information...the tome is neatly designed, well constructed and easy to read." - ISSX Newsletter
"...a useful reference handbook for in vitro ADMET assays." - ChemBioChem
Kommentar zu "Optimization in Drug Discovery"
0 Gebrauchte Artikel zu „Optimization in Drug Discovery“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Optimization in Drug Discovery".
Kommentar verfassen